How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Surgical Booms Market
- By Product Type: Ceiling Mounted Surgical Booms, Wall Mounted Surgical Booms, Mobile Surgical Booms, Floor Mounted Surgical Booms
- By Number of Arms: Single Arm Surgical Booms, Double Arm Surgical Booms, Triple Arm Surgical Booms, Multi-Arm Surgical Booms
- By Application: Operating Rooms, Intensive Care Units (ICU), Emergency Rooms, Diagnostic Imaging Rooms
- By Load Capacity: Light Load Surgical Booms (up to 50 kg), Medium Load Surgical Booms (50-150 kg), Heavy Load Surgical Booms (above 150 kg)
- By Mounting Type: Fixed Surgical Booms, Articulating Surgical Booms, Telescopic Surgical Booms
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Ceiling Mounted Surgical Booms leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Surgical Booms Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Number of Arms 4
Application 4
Load Capacity 3
Mounting Type 3
Companies profiled
Stryker Corporation
Skytron LLC
Getinge AB
Steris plc
Maquet (Getinge Group)
Trumpf Medical
Berchtold Holding GmbH & Co. KG
Drägerwerk AG & Co. KGaA
Steris Life Sciences
Mediland Enterprise
MediPlinth
Mediq Deutschland GmbH
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Skytron LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Getinge AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Steris plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Maquet (Getinge Group)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Trumpf Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Berchtold Holding GmbH & Co. KG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Drägerwerk AG & Co. KGaA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Steris Life Sciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Mediland Enterprise
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →MediPlinth
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Mediq Deutschland GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Bovie Medical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →SurgiTel
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Baxter International Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,114M by 2033 · 9.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Ceiling Mounted Surgical Booms62.3
- Wall Mounted Surgical Booms11.6
- Mobile Surgical Booms12.8
- Floor Mounted Surgical Booms13.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$180.2M → $343.7M · 8.4%
Europe$125.6M → $260.9M · 9.6%
Asia Pacific$114.7M → $221.6M · 8.6%
Latin America$71.0M → $143.7M · 9.2%
Middle East and Africa$54.6M → $118.9M · 10.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.262026
9.292027
9.292028
9.302029
9.312030
9.322031
9.352032
9.362033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Stryker Corporation15.5
- Skytron LLC17.2
- Getinge AB12.7
- Steris plc9.1
- Maquet (Getinge Group)11.8
- Trumpf Medical5.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type16.7%
Number of Arms13.3%
Application35.7%
Load Capacity12.3%
Mounting Type22.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.6
- Europe24.0
- Asia Pacific20.4
- Latin America13.2
- Middle East and Africa10.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Stryker Corporation | 77 | 92 | 77 | 91 | 91 | 84 | 85 |
| Skytron LLC | 88 | 85 | 79 | 73 | 74 | 89 | 81 |
| Getinge AB | 88 | 76 | 65 | 81 | 71 | 72 | 76 |
| Steris plc | 81 | 60 | 69 | 65 | 74 | 82 | 72 |
| Maquet (Getinge Group) | 59 | 60 | 56 | 70 | 63 | 71 | 63 |
| Trumpf Medical | 50 | 59 | 64 | 59 | 71 | 60 | 61 |
| Berchtold Holding GmbH & Co. KG | 41 | 64 | 63 | 65 | 56 | 42 | 55 |
| Drägerwerk AG & Co. KGaA | 60 | 47 | 40 | 36 | 50 | 40 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Stryker Corporation
- Skytron LLC
- Getinge AB
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Stryker Corporation | ◐ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Skytron LLC | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| Getinge AB | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Steris plc | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Maquet (Getinge Group) | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Trumpf Medical | − | ◐ | ◐ | ◐ | ✓ | ◐ |
| Berchtold Holding GmbH & Co. KG | − | ✓ | ◐ | ◐ | − | ◐ |
| Drägerwerk AG & Co. KGaA | ◐ | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Stryker Corporation85
2Skytron LLC81
3Getinge AB76
4Steris plc72
5Maquet (Getinge Group)63
6Trumpf Medical61
7Berchtold Holding GmbH & Co. KG55
8Drägerwerk AG & Co. KGaA46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Stryker CorporationSkytron LLC
Challenger2
Strong scale, closing on the leaders.
Getinge ABSteris plc
Contender2
Focused players with pockets of strength.
Maquet (Getinge Group)Trumpf Medical
Niche2
Specialists in a single segment or region.
Berchtold Holding GmbH & Co. KGDrägerwerk AG & Co. KGaA
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Surgical Booms Market — a $113M beachhead inside a $1.87B market.
Beachhead (SOM)$113Mobtainable near-term
Serviceable (SAM)$725Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Ceiling Mounted Surgical Booms
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Wall Mounted Surgical Booms
Strong fit — clear ROI and a fast path to value.
End user67 fit
Mobile Surgical Booms
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Number of Arms & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel25%
Digital / self-serve22%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Surgical Booms Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified26%
Evaluation11%
Closed-won6%
$9.2KCAC
$43KLTV
4.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Surgical Booms Market is a high-growth opportunity — $5.71B by 2033, compounding at 11.6%.
TAM · 2025$2.37Btoday
TAM · 2033$5.71Bforecast
CAGR11.6%2027–2033
Cumulative$34.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.71BTotal addressable market
SAM$2.40BServiceable available market
SOM$408MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.71BLarge & growingTAM by 2033 at 11.6% CAGR
$2.40BServiceable nowreachable with today’s model
$408MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.46BBear7.6% CAGR
$5.71BBase11.6% CAGR
$7.32BBull15.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Number of Arms optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Surgical Booms Market — a $6.24B market by 2033. Plan: grow share from 6.9% to 12.7%.
Market size · 2033$6.24Btotal addressable
Market CAGR10.1%2027–2033
Target share12.7%from 6.9% today
Revenue ambition$793Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 12.7% | At risk |
| Revenue | $389M | $793M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 29.5% | 45.7% | On track |
| Customer retention | 88.3% | 96.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Number of Arms capability
A defensible second engine — invest in Number of Arms to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Number of Arms
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $108M capacity & capability investment
- Greenlight bolt-on M&A in Number of Arms
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Surgical Booms Market conversation — a $4.99B market you can size, segment and defend in minutes.
Market size · 2033$4.99Btotal opportunity
Growth6.1%CAGR to 2033
Addressable buyers1,053+accounts in scope
Typical ROI4.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.4×return on cost, year one
< 4 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Stryker CorporationSkytron LLCGetinge ABSteris plcMaquet (Getinge Group)Trumpf MedicalBerchtold Holding GmbH & Co. KGDrägerwerk AG & Co. KGaA+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Surgical Booms Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Surgical Booms Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Emergency Contraceptive Pills Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportPregnant Vitamin Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportSaffron Tablets Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportZonisamide Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportPolycystic Ovary Syndrome (PCOS) Drugs Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportIdiopathic Short Stature Drug Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportEPA/DHA Omega-3 Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportNeisseria Gonorrhoeae Infections Treatment Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportSore Throat Remedies Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportNonstructural Protein 4B Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportAntimalarial Medication Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportHPV Reagent Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.